Ambit Biosciences

For profit

Also known as: Ambit Biosciences Corporation | Interim Chief Medical Officer / Ambit Biosciences Corporation | Interim Chief Medical Officer, Ambit Biosciences Corporation | Medical Monitor, Ambit Biosciences Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2007

Last known activity

Apr 10, 2019

Acquired by Daiichi Sankyo on Sep 28, 2014

Timeline

2000s

Jan 1, 2000
Ambit Biosciences— Founded

2010s

Sep 28, 2014
Daiichi Sankyo— Acquired By

Drugs by trial phase (10 distinct, 12 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (15)

NCT03845881CollaboratorEarly Phase 1Apr 10, 2019
NCT01892371CollaboratorPhase 1/Phase 2Nov 1, 2013
NCT01468467Study directorPhase 1Apr 1, 2012
NCT01565668CollaboratorPhase 2Apr 1, 2012
NCT01468467CollaboratorPhase 1Apr 1, 2012
NCT01565668Study directorPhase 2Apr 1, 2012
NCT01390337CollaboratorPhase 1Oct 1, 2011
NCT01390337Study directorPhase 1Oct 1, 2011
NCT01411267CollaboratorPhase 1Aug 1, 2011
NCT01287858Study directorPhase 1Nov 1, 2010
NCT01245543Study directorPhase 1Nov 1, 2010
NCT01049893Study directorPhase 1Jan 1, 2010
NCT00989261Study directorPhase 2Nov 1, 2009
NCT00979173CollaboratorPhase 1Nov 1, 2009
NCT00462761Study directorPhase 1Jan 1, 2007

Details

Founded: San Diego, CA, US Jan 1, 2000
Last known activity: Apr 10, 2019